554. Mannacio VA, Iorio D, De Amicis V, et al. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a ran- domized trial. J Thorac Cardiovasc Surg. 2008;136:1541 8. 555. Liakopoulos OJ, Choi YH, Haldenwang PL, et al. Impact of preop- erative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30 000 patients. Eur Heart J. 2008;29:1548 59. 556. Knatterud GL, Rosenberg Y, Campeau L, et al., Post CABG Investi- gators. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagu- lation in the post coronary artery bypass graft trial. Circulation. 2000; 102:157 65. 557. Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg. 1999;15:394 9. 558. Pascual DA, Arribas JM, Tornel PL, et al. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery. Ann Thorac Surg. 2006;81:78 83. 559. Pan W, Pintar T, Anton J, et al. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004;110:II45 9. 560. Deleted in proof. 561. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes [published correction appears in N Engl J Med. 2006;354:778]. N Engl J Med. 2004;350:1495 504. 562. Cannon CP, Steinberg BA, Murphy SA, et al. Meta-analysis of car- diovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol. 2006;48:438 45. 563. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227 39. 564. FDA Safety Alert. Zocor (simvastatin): increased risk of muscle injury with high doses. 